ZOMETA® Effectively Inhibits Bone Destruction in ZOMETA® Lung Cancer Patient Case Study

View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics

ZOMETA is the current standard of care for the prevention of skeletal-related events (SREs)

ZOMETAŽ Lung Cancer Patient Case Study Anthony

Anthony P.

Aged 64 years
Retired auto mechanic
Quit smoking 10 years ago

Page

1 2 3

The vicious cycle of bone destruction is ongoing in patients like Anthony

Osteoclasts and osteoblasts continually weaken bone in a vicious cycle of destruction^7,8

osteoclasts and osteoblasts continually weaken bone in a vicious cycle of destruction

Because bone is constantly being attacked even when the primary tumour is in remission, ZOMETA^® must be dosed every 3 to 4 weeks^7,9

Page

1 2 3

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

The vicious cycle of bone destruction is ongoing in patients like Anthony

Because bone is constantly being attacked even when the primary tumour is in remission, ZOMETA® must be dosed every 3 to 4 weeks7,9

Because bone is constantly being attacked even when the primary tumour is in remission, ZOMETA^® must be dosed every 3 to 4 weeks^7,9